Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

WHO Study Finds Remdesivir Has Little or No Effect on Preventing Deaths


The World Health Organization (WHO) said the Antiviral Drug, Remdesivir, One of the many Drugs Trump was given to Treat his Coronavirus Infection, has “little to no effect” on Mortality for Patients Hospitalized with the Coronavirus.

WHO looked at Four Therapeutics in a Study covering more than 11,000 Coronavirus Patients in 30 Countries.

Along with Remdesivir, the Study analyzed the use of Hydroxychloroquine, a Combination of the Anti-HIV Drugs Lopinavir, Ritonavir, and Interferon.

“For each drug in the study, the effect on mortality was disappointingly unpromising,” WHO said. The Study hasn’t been Published in a Peer-Reviewed Journal, but WHO Published the Results itself.

The Disappointing Result differs from an Earlier Study in the U.S. that Found Remdesivir Shortens Recovery Time by about a Third in those Hospitalized with Serious Illness.










NYC Wins When Everyone Can Vote! Michael H. Drucker


     
 
 


This post first appeared on The Independent View, please read the originial post: here

Share the post

WHO Study Finds Remdesivir Has Little or No Effect on Preventing Deaths

×

Subscribe to The Independent View

Get updates delivered right to your inbox!

Thank you for your subscription

×